TABLE 3.
Strain | IC50 (nM)* |
A/KANAGAWA/IC1890/2019 (H1N1pdm09, PA I38T) | 79.2 ± 26.6 |
A/KANAGAWA/ZC1905/2019 (H1N1pdm09, NA H275Y) | 55.4 ± 26.7 |
A/KITAKYUSYU/36/2015 (H3N2, NA E119V) | 31.4 ± 16.5 |
*The half-maximal inhibitory concentration (IC50) was determined from the result of the plaque assay. Average values with standard deviations from three independent experiments were shown.